06/12/2025
7:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2025
4:32 PM | Baynes Roy D. (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:32 PM | Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:33 PM | Lacey David L. (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:33 PM | Nurix Therapeutics (Issuer)
Saltzman Edward C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:33 PM | GREGORY JULIA P (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:33 PM | Kunkel Lori Anne (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:33 PM | Nurix Therapeutics (Issuer)
Silva Paul M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:32 PM | Nurix Therapeutics (Issuer)
Reinsdorf Judith A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
7:44 AM | Deep Track Capital, LP (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/12/2025
9:44 AM | Nurix Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for NRIX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/02/2025
5:18 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
3:22 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2025
6:35 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
6:35 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
6:35 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2025
7:57 PM | BlackRock, Inc. (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/08/2025
3:02 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2025
3:06 PM | Nurix Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/28/2025
1:06 PM | Nurix Therapeutics (Filer)
| Form DEFA14A | |
03/28/2025
8:03 AM | Nurix Therapeutics (Filer)
| Form ARS | |
03/28/2025
5:03 AM | Nurix Therapeutics (Filer)
| Form DEF 14A | |
03/03/2025
4:29 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:17 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
3:31 PM | Deep Track Capital, LP (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/14/2025
7:42 AM | Deep Track Capital, LP (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025
3:12 PM | Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
7:03 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:33 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
6:48 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
6:53 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
6:43 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
3:15 PM | Nurix Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/13/2025
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
8:33 PM | ARK Investment Management LLC (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/02/2025
4:28 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:20 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
5:54 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
10:34 AM | FMR LLC (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/02/2024
5:00 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:00 PM | Nurix Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. This little-known company holds nearly 100 patents and trades for around $7 |
11/14/2024
11:48 AM | Nurix Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Nurix Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/07/2024
4:37 PM | MORGAN STANLEY (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
4:48 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
4:57 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
4:57 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:50 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:41 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:36 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
10/31/2024
3:12 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
3:01 PM | Nurix Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/30/2024
7:30 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:30 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:30 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:41 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:47 PM | Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2024
3:48 PM | Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:16 AM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Nurix Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/01/2024
6:36 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:32 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
6:01 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
4:33 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:28 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
5:23 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:41 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:24 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:25 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
6:06 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
6:06 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:31 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
6:06 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
6:06 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
6:06 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
3:06 PM | Kunkel Lori Anne (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
